Viewing StudyNCT06483347



Ignite Creation Date: 2024-07-17 @ 11:05 AM
Last Modification Date: 2024-10-26 @ 3:33 PM
Study NCT ID: NCT06483347
Status: RECRUITING
Last Update Posted: 2024-07-03
First Post: 2024-06-23

Brief Title: Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Organization: Second Affiliated Hospital of Guangzhou Medical University

Conditions & Keywords Data

Conditions:
Name
Lung Cancer
Inoperable Disease
Keywords:
Name View
Inoperable lung cancer View
Intra-tumor injection View
Immunotherapy View
First line therapy View